Right Ventricular Dysfunction in Patients Experiencing Cardiotoxicity during Breast Cancer Therapy
Background. Right ventricular (RV) dysfunction during cancer therapy related cardiotoxicity and its prognostic implications have not been examined. Aim. We sought to determine the incidence and prognostic value of RV dysfunction at time of LV defined cardiotoxicity. Methods. We retrospectively iden...
Main Authors: | Anna Calleja, Frédéric Poulin, Ciril Khorolsky, Masoud Shariat, Philippe L. Bedard, Eitan Amir, Harry Rakowski, Michael McDonald, Diego Delgado, Paaladinesh Thavendiranathan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2015/609194 |
Similar Items
-
Role of Oxidative Stress in the Mechanisms of Anthracycline-Induced Cardiotoxicity: Effects of Preventive Strategies
by: Rodrigo Carrasco, et al.
Published: (2021-01-01) -
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
by: Maria Isabel Camara Planek, et al.
Published: (2020-07-01) -
Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
by: Alessandra Murabito, et al.
Published: (2020-03-01) -
Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics
by: Lynne K. Williams, et al.
Published: (2017-08-01) -
Aortic Thrombus Formation During Venoarterial Extracorporeal Membrane Oxygenation for Ventricular Septal RuptureNovel Teaching Points
by: Omid Kiamanesh, MD, et al.
Published: (2020-11-01)